Clinical trial
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG)…
NCT02006693 · AqueSys, Inc., Industry · Completed
Key facts
| NCT number | NCT02006693 |
|---|---|
| Title | Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants |
| Official title | Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects |
| Lead sponsor | AqueSys, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Primary Open Angle Glaucoma |
| Intervention type | Device, Procedure |
| Interventions | XEN® Gel Stent, Cataract Surgery |
| Enrollment | 199 |
| Start date | Dec 5, 2013 |
| Primary completion | Feb 9, 2016 |
| Completion | Jan 26, 2017 |
| First posted | Dec 10, 2013 |
| Last update posted | Apr 22, 2019 |
| Countries | Austria, Belgium, Germany, Italy, Poland, Spain, Switzerland, United Kingdom, Venezuela |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: